 NEW YORK, May 6, 2021 PRNewswire -- Relmada Therapeutics, Inc. Nasdaq: RLMD, a late-stage biotechnology company addressing diseases of the central nervous system CNS, today announced that it will report its financial results for the first quarter ended March 31, 2021 after the market close on Wednesday, May 12, 2021. The company will host a corporate update conference call and live audio webcast at 4:30 PM Eastern Time on Wednesday, May 12, 2021. 